пресс-релиз

July 6, 2020

Heta compiler has been published on GitHub as an OpenSource

(Moscow-06.07.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platforms. Particularly, it allows combining modules written in different formats like: Heta language code, Excel sheets, JSON, YAML formatted structures, SBML and transforming them into the dynamic models of different formats.

Подробнее о InSysBio to announce the launch of its new tool Heta compiler

InSysBio to welcome its new team member Dr. Neil Benson

события

June 17, 2020

InSysBio announces the appointment of Dr. Neil Benson as Principal Consultant in area of business development

(Edinburgh-Moscow-16.06.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, is proud to announce its new team member Dr. Neil Benson! Dr. Benson has joined InSysBio as Principal Consultant in area of business development of both INSYSBIO LLC and INSYSBIO UK LIMITED. In his capacity as Principal Consultant to InSysBio, he will support further development of the outstanding IO and AD QSP offering of the company.

Подробнее о InSysBio to welcome its new team member Dr. Neil Benson

InSysBio to announce the launch of QSP model of COVID-19

June 2, 2020

The new open source project to be developed and updated Online

InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the launch of its fundamentally new project in response to the ongoing global threat, the open source QSP model of COVID-19. In accordance with its mission, which is to assist pharmaceutical industry to speed up the delivery of the cure to patients, InSysBio team could not stay aside. Thus, the aim of the new project is to develop QSP model of COVID-19 describing virus and host cell life cycles, innate and adoptive immune response and possible therapeutic treatments.

Подробнее о InSysBio to announce the launch of QSP model of COVID-19

InSysBio to announce the release of its new database Cytocon DB 1.1

March 31, 2020

Cytocon DB 1.1 facilitates access of QSP modelers to baseline in vivo data in public domain

(Moscow - 31.03.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, has released its new Cytocon DB 1.1. The name of the database derives from Cell and cYTOkine CONcentrations.

Подробнее о InSysBio to announce the release of its new database Cytocon DB 1.1

InSysBio presents an enhanced version of its Immune Response Template Database

February 21, 2020

IRT Version 3.0.0 acquires a wide variety of updates and new options

(Moscow – 21.02.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) platform development and provision, moves forward to the future.

Подробнее о InSysBio presents an enhanced version of its Immune Response Template Database

PK/RO simulator for anti-PD-1 mAbs

November 25, 2019

InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP), modeling and simulation for drug development, announced the launch of application ‘PK/RO simulator for anti-PD-1 mAbs’. The application is based on the model allowing to predict pharmacokinetics and target binding in human for therapeutic antibodies against PD-1 receptor.

Подробнее о PK/RO simulator for anti-PD-1 mAbs

Компания InSysBio официально опубликовала библиотеку LikelihoodProfiler для анализа идентифицируемости

8 февраля 2019

Компания InSysBio опубликовала библиотеку LikelihoodProfiler, предназначенную для анализа идентифицируемости, в официальном репозитории языка Julia.

Подробнее о Компания InSysBio официально опубликовала библиотеку LikelihoodProfiler для анализа идентифицируемости

InSysBio Announces Continuation of Collaboration with MedImmune for Quantitative Systems Pharmacology Modeling in Systemic Lupus Erythematosus

October 1, 2018

InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP), modeling and simulation for drug development, announced today an extension of a collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, for QSP modeling in systemic lupus erythematosus (SLE). The goal is to support the clinical development of anifrolumab, an investigational monoclonal antibody against the type I interferon receptor, by modeling the contributions of key cell types involved in the pathophysiology of lupus that are associated with the type I interferon dysregulation commonly seen with the disease.

Подробнее о InSysBio Announces Continuation of Collaboration with MedImmune for Quantitative Systems Pharmacology Modeling in Systemic Lupus Erythematosus

InSysBio launches Immune Response Template online

September 26, 2018

InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the launch of Immune Response Template (IRT) online. IRT is a QSP platform of human immune system and a tool for development of custom QSP models related to immune response.

Подробнее о InSysBio launches Immune Response Template online

InSysBio launches Alzheimer’s Disease Modeling Consortium

September 11, 2018

InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the launch of Alzheimer’s Disease (AD) Modeling Consortium. The aim of the consortium is the support of drug development in AD by consolidation of efforts of teams from various pharmaceutical companies in framework of development and application of AD QSP platform.